Position in HIMS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$165,264,292
+$56,464,955 QoQ
Shares Held
4,766,781
-9.0% QoQ
Ownership
2.04%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#9
of 504 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in HIMS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $2,415,050,910 across 61 Drug Manufacturers - Specialty & Generic names. HIMS ranks #4 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
6,398,674 | $1,078,432,506 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,981,234 | $236,524,202 | |
| 3 | ZTS |
Zoetis Inc.
|
2,624,825 | $188,619,917 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
This page
|
4,766,781 | $165,264,292 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
275,358 | $149,197,220 | |
| 6 | VTRS |
Viatris Inc
|
7,322,267 | $116,277,595 | |
| 7 | HLN |
Haleon plc
|
10,824,395 | $100,991,599 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
699,229 | $77,572,458 |
All Filings in HIMS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $165,264,292 | 4,766,781 | Shares | Other | 2026-08-12 | |
| 2026-03-31 | $108,799,337 | 5,240,816 | Shares | Other | 2026-05-13 | |
| 2026-02-27 | $56,363,590 | 3,881,790 | Shares | Sole | 2026-03-05 | |
| 2025-12-31 | $611,678,622 | 18,838,270 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $1,008,826,736 | 17,786,085 | Shares | Other | 2025-11-07 | |
| 2025-06-30 | $136,607,690 | 2,740,375 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $77,680,445 | 2,628,780 | Shares | Other | 2025-05-12 | |
| 2024-12-31 | $65,528,137 | 2,710,014 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $37,763,245 | 2,050,122 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $51,568,609 | 2,554,166 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $4,892,402 | 316,251 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $1,486,299 | 167,000 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $1,047,598 | 166,550 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,670,219 | 177,683 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,489,011 | 351,715 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $804,383 | 125,489 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $626,148 | 112,213 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $509,914 | 112,564 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $188,324 | 35,333 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $615,305 | 93,940 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $734,592 | 97,426 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $168,141 | 15,440 | Shares | Defined | 2021-08-12 | |
| No filing history on record for this holder in this stock. | ||||||